NPY and atherosclerosis: Previous reports demonstrated the elevated NPY expression in VSMCs in atherosclerotic lesions of animal model (44), aggravation of atherosclerotic plaque by local delivery of NPY (41), and amelioration of atherosclerosis with NPY receptor antagonism (43), strengthening the notion that NPY may be implicated in atherosclerotic plaque destabilization.